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ABSTRACT 
The current article aims with the introduction of newer solubility enhancing technique as Liquisolid-pellet. The majority of newly invented 
molecules comes under the biopharmaceutical classification system (BCS) Class II, IV indicating poor solubility and thereby poor bioavailability. 
Liquisolid Compaq is one of the solubility enhancement techniques used for improving solubility and dissolution of the molecule by incorporating 
non-volatile solvent followed by carrier and coating agents. However, this technique is only applicable to potent molecules as a higher dose resulted 
in inconvenience to the patient and difficult to swallow. Another drawback of this method is not suitable for pilot plant scale-up. Liquisolid pellet 
technique overcoming all limitations of Liquisolid Compaq and offers good compaction, flowability, dose accuracy, less gastric irritations, and better 
bioavailability. In the Liquisolid-Pellet technique, powdered material received from Liquisolid Compaq is further moistened with granulating fluid 
to provide enough plasticity. The material is subjected to extrusion using an extruder to generate extrudates. The extrudates are placed under the 
spheronizer to form spherical particles as Pellets. The pellets are mainly prepared by extrusion-spheronization and hence, articles elaborate details 
of extruders and spheronizers, their specifications as well as factors, which strongly impart processing. These pellets are filled in capsules according 
to their dose and utilized as an immediate release or sustained release. The literature related to this review was collected from Science Direct, 
PubMed, Google Scholar, Google, USPTO, etc. from 1998 to 2020 with the following key-words.  
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INTRODUCTION  
Most preference allotted to solid orals owing to their convenience, 
compliance, uniformity, and stability [1]. Several characteristics of 
the active ingredient and functional excipients like solubility, 
dissolution rate, presystemic metabolism, etc. have a strong 
impact on their bioavailability [2]. Most of the newly invented 
molecules, around 90 % and 40 % of approved active 
pharmaceutical ingredients, showed poor solubility in water and 
ultimately low bioavailability [3]. Hence, one of the simplest 
attempts to improve the bioavailability is to accelerate their 
solubility and dissolution rate. Drug permeability is a property 
that affects oral bioavailability. The outcome of drug design and 
development introduced the molecules with high lipophilic and 
molecular weight characteristics, which failed to show good 
solubility and, ultimately bioavailability [4].  
The active ingredient is considered as highly soluble when their 
highest dose is solubilized in a solvent of 250 ml at the entire pH 
range (1-7), reported by FDA and BCS. Moreover, the active 
ingredient is categorized as permeable when its absorption across 
the intestine will be 90 percent. BCS reported that there is a definite 
relationship between dissolution and bioavailability observed 
outside and inside of the body, termed as IVIVC. Rely on solubility 
and permeability, active ingredient categorized into four classes and 
out of them, class II and IV is a good candidate for improving the 
bioavailability [5-7]. Several techniques have been implemented for 
improving the solubility and bioavailability depicted in table 1 [8]. 
 
Table 1: Several approaches for enhancing the bioavailability of drugs 





Supercritical fluid recrystallization [11] 
Spray freezing into liquids [12] 
Using surfactants [13] 
Using salt form [14] 
Using precipitation inhibitors [15] 
Solid Dispersion [16] 
Using cyclodextrins [17] 
Enhancing 
permeability 
Microemulsions, Self-micro emulsifying drug delivery system (SMEDDS), self-nanoemulsifying drug 
delivery system (SNEDDS) 
[18] 
[19] 
Solid lipid nanoparticles (SLN) [20] 
Nanostructured lipid carrier (NLC) [21] 
Liposomes [22] 
Penetration enhancers [23] 
Enhancing stability Enteric coating [24] 
Using metabolism inhibitors [25] 
 
Liquisolid compaq technique 
The Liquisolid concept was first demonstrated by Spireas and his 
team described that the active ingredients mostly exist as powder 
and hydrophobic. Their solubility was improved by incorporating a 
liquid that is non-volatile to make it available as a solution or 
suspension [26-27]. Excipients functioning as a carrier and having 
good adsorption characteristics with porosity should be preferred 
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and added to the above solution or suspension. Moreover, the 
incorporation of a coating agent in solution or suspension improved 
the flow behavior of powder and make it available as directly 
compressible to formulate as tablets [28]. 
The non-volatile solvent should be selected based on the highest 
solubility of the active ingredient in the solvent. Greater solubility of 
active ingredient resulted in improved dissolution and 
bioavailability [29]. One of the limitations of the Liquisolid technique 
is that it applies only for a minimum dose of drugs. Active 
ingredients are having a weight of more than 400 mg found to be 
poor candidates, as they required a large amount of solvent for 
solubilization. The addition of more amount of solvent needs an 
excess quantity of carrier and coating agent. This ultimately resulted 
in a higher weight of the finished product, which is difficult to 
swallow. Hence, this method is not suitable for high doses [30]. 
 
 
Fig. 1: Manufacturing steps involved in liquisolid technique 
 
Liquisolid pellet technique 
Mathew Lam et al. 2019 developed the Liqui-pellet, a new solubility 
enhancing technique for enhancing oral bioavailability of BCS class 
II/IV drugs. Liqui-pellet comes from combining the concept of the 
Liquisolid Compaq technique with pelletization technology. Firstly, 
it was postulated that the Liqui-pellet was different from the 
Liquisolid technique from the definition point of view [31]. The 
Liqui-pellet cannot be considered as the Liquisolid Compaq 
technique, as it is based on the concept of powdered material, which 
is moist and not as freely flowable. Whereas, Liqui-pellet al. so 
showed good flowability characteristics and available in the form of 
pellets. Liqui-pellet technique overcomes the limitations of 
Liquisolid Compaq, where a higher dose can also be suitable for 
improving the solubility and final weight is quite low [32].  
Matthew Lam and his coworkers provided further clarification in 
2020, that the Liquisolid-pellet were different from the Liqui-pellets. 
Spireas in his patent, described that the Liquisolid powders should 
be flowable by adding more carriers, which in turn reduces load 
factor and makes the final dosage form, which was very bulky. As it 
contains a high load factor, a wet mass system, which is a non-
flowable powder, should be produced, which was different from the 
Liquisolid system, which is a flowable powder. Hence, on that basis, 
differentiated the terms, the Liqui-pellet uses the Liqui-mass system, 
whereas Liquisolid-pellet uses the Liquisolid system [33]. 
 
 
Fig. 2: Advantages of liquisolid-pellet technology 
 
Formulation components of the liquisolid-pellet technique 
1. Selection of drug candidate:  
Drugs with low oral bioavailability are a good candidate for this 
technique. Drug candidates classified as class II/IV as per BCS is to 
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be chosen for enhancement of bioavailability. E. g. Carbamazepine, 
Naproxen and Ritonavir, etc. [34-36]. 
2. Selection of Non-volatile solvent (NVS): 
They possess inertness, high boiling point, and lower viscosity. 
Generally, the less viscous liquid should be preferred as it requires a 
minimum amount of carrier and coating agent to generate free-
flowing powder as well as minimizes tablet weight. E. g.  
Polyethylene glycol 200/400/600, propylene glycol, Polysorbate 
20/80, Span, Labrafil, Labrasol and Kolliphor EL, etc. [37-40]. 
3. Selection of Carrier material:  
Carrier material should be incorporated for compression enhancing. 
These materials are porous with enough soaking tendency. Several 
derivatives of cellulose, starch, lactose are used as carrier material. 
Carrier material should be selected based on its absorption capacity 
and inertness with drugs.  
4. Selection of coating material:  
Coating material should be having good flow characteristics and 
possess high adsorptive property. Various grades of silica are widely 
used for coating. They are primarily utilized for adsorption behavior 
and thereby providing the material as freely flowable [39-40]. 
5. Additional excipients:  
Liquisolid-Pellet system requires additional excipients used as 
Disintegrants, directly compressible excipients, and lubricants, etc. 
[41-43].  
Manufacturing process for liquisolid-pellet technique 
The manufacturing process involved in the Liquisolid-Pellet technique 
involves the utilization of both processes as the Liquisolid technique 
followed by extrusion-Spheronization. According to the solubility of 
the drug, non-volatile solvents should be chosen. The active 
ingredients should be rapidly dispersed in a non-volatile solvent, 
which results in the formation of liquid medication or as a drug 
solution. This drug solution was sonicated for about 10-15 min until a 
clear homogenous solution is obtained. Microcrystalline cellulose 
should be mixed with solution or suspension as a carrier, which is also 
a filler and binder for further process of extrusion-Spheronization. 
Finally, cross povidone is incorporated as a disintegrating and coating 
agent, which gives, moisten powder material as Liquisolid system [44]. 
The prepared Liquisolid mixture is then further gradually wetted 
with solvent so that enough plasticity is generated for extrusion-
Spheronization. The wet mass is then rapidly undergoing extrusion 
using an extruder through a desired mesh. The extrudates obtained 
is then quickly transferred to Spheronization, so that good quality of 
pellets will be formed. The formed pellets are then dried in a 
fluidized bed dryer for about 10-20 min. The dried pellets are 
further compressed to form tablets or filled in capsules [45]. 
 
 
Fig. 3: Manufacturing steps involved in liquisolid-pellet technology 
 
Extrusion-spheronization 
Extrusion-spheronization is the most widely used technique for the 
manufacturing of pellets. Pellets are defined as ‘’small, free-flowing, 
spherical units made up of fine powders or granules of bulk drugs and 
excipients by involving mostly extrusion and spheronization.’’ The 
prepared pellets can be utilized for rapid release or controlled release. 
One of the big advantages of extrusion-spheronization technology is 
that a large number of active ingredients can be loaded in pellets as 
compared with other techniques for pellets production [46]. 
Manufacturing of pellets via extrusion-spheronization 
The process of extrusion-spheronization involves several steps as, 
a. The material utilized for processing should be dried completely 
for further mixing to get uniformity in powder dispersion. 
b. Then the material is wetted to create enough plastic wet load or 
mass. 
c. The obtained wet mass further undergoes extrusion to generate 
rod-shaped particles.  
d. These rod-shaped particles further spheronize so that spherical 
particles are generated. 
e. The spherical particles are further dried and screen to achieve 
the desired particle size [47]. 
Types of extruders 
Extruders are generally composed of 2 portions; the delivery and die 
system. The delivery system responsible for the movement of 
material and mixing of the material, whereas die systems helps in 
generating the material in the desired shape. Based on the feed 
mechanism, extruders are classified as follows. 
1. Screw feed extruder containing axial, dome, and radial type 
2. Gravity feed extruder consisting of cylinder roll, gear roll, and 
radial type. 
3. Piston feed or Ram extruder  
4. Screen or Basket extruder 
5. Roll extruder [48] 
Screw feed extruders 
Make use of the screw for creating pressure required to propel the 
material so that it will flow. Rely on the design, solid substances 
move via several openings, thereby resulted in similar strands, 
which are commonly known as extrudates. They composed of single 
or twin helical screws revolving in a barrel and hence shifted the 
solid material from the hopper to the die. The die system is 
consisting of a thin steel plate with several holes and available in the 
form of an axial or radial screw feeder. 
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Fig. 4: Steps involved in manufacturing of pellets 
 
Table 2: Types of screw extruder and their specifications 
S. No. Screw 
extruder 
Description Advantages  Features  Reference 
1 Axial Mostly employed in pellet 
formation with size ranges 
from 400 µ to 2000 µ.  
Provides a minimum output 
of 250 g and a maximum of 
150 kg/h. 
Axial mesh with feed hopper and 
pressing cams and a screws 
Available as a screen along with 
hopper and compressing cams 
with a screw. 
Rotates at 20-100 rpm. 
Available at touch screen with 
traceability 
Easy to operate and clean. 
Build the main part with stainless 
steel 316 grade and rest with 304. 
The maximum product recovered 
up to 100 %. 
Created low fines after the 
operation 
Available in several axial meshes 
as 0.2, 0.3, 0.4, 0.5, 0.6, 0.8, 1 and 
1.2 mm. 
[49] 
2 Dome The Dome extruder presses 
300-1200 µ of particle sizes. 
Providing an output of a 
minimum of 100 to 200 g and 
max. of 6 kg/h. 
Operated at 40-100 rpm. 
Available as pressing cams with 
screw and hopper. 
Similar to axial  [49] 
3 Radial Capable of producing an 
extrudate of 400 to 1500 µ 
particles. 
Operated at speed of 20-100 rpm. Similar to axial. [49] 
 
Gravity feed extruders 
They composed with moving gear and cylinder, which further 
merged into roll extruders. They utilize rollers, which create 
pressure on the material and generates extrudate. These extruders 
generated extrudate by exerting pressure on the wetted mass by 
utilizing two rollers. The cylinder type extruder with two rollers 
available in the form of a cylinder as solid and other with a hollow 
cavity to generate dies. Whereas gear type extruders are also 
containing rollers with gear. The third type of extruder is radial in 
which arms are rotated so that wetted mass passed with pressure. 
Due to the presence of a rotating blade, they tear the wetted material 
and capable of generating extrudate. These are differentiated from 
gravity and screw extruder in the aspect of not using compression 
before extrusion. 
Ram extruder 
This type of extruder is based on the concept of utilizing a ram or 
plunger alternatively to screw. In this type of extruder, the piston 
displaces and drive the material towards the die at the opposite end [50].  
Screen or basket extruder 
Screen or sieve type extruders composing a chamber that grip the 
material and enabled them to extrude. The spinning section pushes the 
material through a porous screen or sieve, thereby producing tiny or 
long extrudates. The formation of these extrudates relies on the presence 
of moisture content. Whereas basket extruder differs from the screen 
extruder as it is placed horizontally and vertically, respectively. 
Roll extruder 
It is also known as Pellets mill, worked by suppling materials 
between a ring die or plate and roller. The designing of the roll 
extruder consisting of a ring die plate that revolves inside of the 
cylindrical die chamber and each one revolving on a fixed plane. 
Every part which is capable of spinning is in the same directions. 
The substances are added to the interior surface of the die and hence 
rollers compress them outsides. 
Impact of factors on extrusion-spheronization 
Moisture content 
The amount of water or moisture available in the solid materials 
determines the effective processing of extrusion as well as the 
quality of pellet formation. Enough amount of moisture content is 
desirable during extrusion as a lower amount resulted in the 
generation of dust particles during spheronization. If the moisture 
content is beyond their limits, then it also affects the process by 
forming agglomerates. The moisture content in the material also 
affects the density of spherical particles, its surface characteristics 
and the torque of an extruder [52]. Lustig-Gustafsson et al. reported 
that the quantity of water necessary for pellet formation depended 
on the active ingredient and its particle size [53]. 
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Types of spheronizers 
 
Table 3: Spheronizer and its features 
S. No. Types  Salient features Reference 
1 Micro spheronizer Applicable only for small labs and trial purpose [51] 
2 Multi bowl spheronizer 
250 
Design with the intention of laboratory-scale indicating minimum quantity. 
Capacity: ranges from 1 g to 1 kg 
Used along with screw extruder 20 and mini screw extruder 
[51] 
3 Model 380 spheronizer Implemented for producing smooth and spherical pellets 
Capacity: ranges from 0.5 kg to 4 kg 
[51] 
4 Model 500 spheronizer Implemented for producing smooth and spherical pellets 
Capacity: ranges from 1 kg to 11 kg 
[51] 
5 Model 700 spheronizer Produces smooth and regular pellets 
Capacity ranges from 5 kg to 25 kg. 
[51] 
6 Model 700 spin 
spheronizer 
Applicable for continuous production due to the presence of dual drum [51] 
 
Granulating fluids 
The most widely used solvent for granulation is distilled water. 
Additionally, alcohol or a mixture with water is also recommended. 
Dreu et al. observed that the quality of pellet formation changes 
according to the addition of granulating fluids as tested using water 
and a combination of water/alcohol. The mechanical and structural 
characteristics of pellets strongly dependent on the type of 
granulating fluids. This is mainly due to the affection of contraction 
driving and counteracting forces during drying conditions [54].  
Excipient 
The excipients incorporated as carrier and coating agent as well as for 
further processing conditions of extrusion, have a strong impact on 
pellets formation. Fielden et al. evaluated lactose powder when used in 
two different grades as coarse and fine during extrusion showed 
variability in the formation of the spherical shape of pellets. Levis et al. 
evaluated several grades of microcrystalline cellulose as single ultra-
fine (A), in combination with SLS (B) and another PH-101 grade (C). 
The material labeled as A and B showed better yields than C in the 
formulation of indomethacin pellets [55]. Rojas et al. reported that 
MCC II exhibiting good pellet formation properties with good 
flowability, enough mechanical strength, and less friability [56]. 
Sometimes, MCC is not used during extrusion-spheronization as it 
tends to retards the release of the poorly water-soluble active 
ingredients, not compatible with active moiety and adsorption 
tendency. Hence, alternatively cellulose derivatives, HPMC, HPC, PEO, 
cross-linked PVP as well as some synthetic polymers [52].  
Extruders 
The selection of extruder is important for availing good quality of 
pellets. The displacement forces observed in the Ram extruders are 
found to be better than in gravity feed extruders. The pressure or 
strength needed to eject the wetted material through ram extruder 
decreased upon the addition of water. Hence, lowering the water 
content resulted in increasing ejection, thereby influencing the 
quality of spherical units. Small size pellets are generally achieved 
using a screen extruder as compared with ram extruders. In the case 
of roll type extruders, criteria for deciding discharge flowing speed, 
the pressure applied on the screen, and roller torque rely on the 
spacing available between roller blade and screen as well as roller 
turning speed. An axial type screw extruders are capable of 
generating highly dense particles comparatively with radial screw 
extruders. Sonaglio et al. developed paracetamol pellets by using an 
axial and radial type of screw extruder and reported that alterations 
in temperature and time required for extrusion [57] found to be 
higher in an axial type.  
Extrusion screen 
The die aperture present in the screen or plate is available in various 
designs. The type of desired products depending on the selection of 
the screen or the plate. When a thick plate or screen is employed, it 
generates dense products. The thin screens or plates are generally 
straight. The aperture size ranges from 0.5 to 1.5 mm and is 
considered as standard.  
Extrusion speed 
The cumulative yield of any extruder depends on its speed. 
Generally, higher yield is expected from any kind of extruders but 
excessive high speed affects the quality of spherical particles. 
Extrusion temperature 
Fielden et al. evaluated the effects of fluid and MCC by using thermal 
methods. The studies indicated that water or fluid utilized as 
granulating fluids is available in the free form and easily converted 
into the vapors by the process of evaporation, thereby sometimes 
affects the final products [58].  
Friction plate 
It is one of the most important segments of spheronizer having a 
furrowed surface that is responsible for providing frictional forces 
[59]. There are two different types of furrow geometry observed as 
cross-hatch and radial, which work effectively. The more controlled 
action was observed in the radial disc, but not found to be suitable for 
giant diameter discs. The most widely used disc in spheronizer is 
square cross-hatched square design, in which developing surfaces are 
overlaid with a grid of truncated tomb. The material of extrudates with 
a diameter up to 0.8 mm is carried out using a 2 mm pitch plate and for 
3 mm diameter, 3 mm pitch plate is recommended.  
Disk speed and load 
During spheronization, disk speed and load should be remaining 
optimum to achieve better output. If the speed remains low, then 
extrudates will not densify and spherical units not formed. Whereas 
excessive speed than recommended resulted in higher pressure on 
the granular materials, lower porosity, increased breaking tendency 
of granules, pressing of particles. Particularly the revolving speed for 
disks having less than 500 mm diameter should be operated at 
about 200 to 1000 rpm. The optimum speed relies on the properties 
of the material being used and their particle size. Generally, for 
smaller particles, higher speed is chosen and for larger ones, lowers 
speed. It is recommended that, during the initiation of 
Spheronization, velocity is kept higher and later will be slower. The 
quantity of load incorporated is dependent on machine capacity and 
size. A machine with 380 mm diameter, the material is approx. 4 
liters, also depends on the density of that material.  
Product-related parameters  
The materials subjected to Spheronization must have enough 
plasticity to permit distortion to take place during striking. Some of 
the extrudates bearing high cohesive forces, which takes a longer 
time to break and increased processing time. [51] 
Other factors 
The rheology of the material can be altered by using binders, 
lubricants, or by modifying mixing time. In critical cases, Mixer 
Torque Rheometer found very useful for measuring the rheology of 
the material easily and immediately. A sufficient quantity of binders 
must be added, which provides robustness to the granules and 
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minimizes the formation of dusty particles during spheronization. 
Excessive binder concentration resulted in the hardening of 
granules and created difficulties in spherical units [60, 61].  
CONCLUSION 
Oral drug delivery is mostly preferred in pharmaceutical 
developments due to its several advantages. Dissolution is the rate-
limiting steps towards achieving oral absorption and bioavailability. 
Liquisolid Compaq is such a technique utilized for the enhancement 
of poorly soluble active ingredient by incorporating non-volatile 
solvent. However, this technique can’t utilize for drug candidates 
above 400 mg of dose, as higher dose resulted in large size of the 
dosage form, which is difficult to, administered as well as difficult to 
scale up in the Pharmaceutical industry. Hence to provide the 
benefits of this technique and overcoming its limitations, the 
Liquisolid-Pellet technique is introduced. Liquisolid-Pellet technique 
has no such restrictions of dose of drugs and highly scales up and 
more beneficial. This technique generated good quality of pellets 
using the concept of Extrusion-Spheronization, so before proceeding 
to this technique, researchers have to understand the impact of 
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